We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+25.11%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$272M
AUM Growth
+$16.2M
Cap. Flow
-$33.7M
Cap. Flow %
-12.39%
Top 10 Hldgs %
50.22%
Holding
97
New
4
Increased
11
Reduced
69
Closed
10

Top Buys

Rank Stock Value
1
OCLR
Oclaro Inc.
OCLR
+$3.07M
2
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$2.94M
3
OMCL icon
Omnicell
OMCL
+$2.65M
4
SCON
Superconductor Technologies Inc.
SCON
+$2.41M
5
TLAB
TELLABS INC
TLAB
+$1.68M

Top Sells

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$6.1M
2
ARRY
Array Biopharma Inc
ARRY
+$4.63M
3
TEAR
TearLab Corporation
TEAR
+$3.87M
4
STKL
SunOpta
STKL
+$2.79M
5
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$2.7M

Sector Composition

Rank Sector Weight
1 Healthcare 41.42%
2 Technology 31.73%
3 Miscellaneous 17.3%
4 Consumer Staples 4.15%
5 Financials 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
76
Vertex Pharmaceuticals
VRTX
$139B
$711K 0.26%
9,380
-1,208
-11% -$96.1K
OREX
77
DELISTED
Orexigen Therapeutics, Inc.
OREX
$708K 0.26%
11,555
-9,820
-46% -$665K
VVUS
78
DELISTED
Vivus Inc
VVUS
$678K 0.25%
7,292
-10,902
-60% -$1.36M
COV
79
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$631K 0.23%
10,356
-3,049
-23% -$186K
PETX
80
DELISTED
Aratana Therapeutics, Inc.
PETX
$575K 0.21%
35,200
-18,095
-34% -$190K
HTWR
81
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$479K 0.18%
6,540
-830
-11% -$70.8K
VTI icon
82
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$342K 0.13%
3,900
+800
+26% +$69.5K
ACHN
83
DELISTED
Achillion Pharmaceuticals
ACHN
$253K 0.09%
83,632
-18,680
-18% -$128K
VCSH icon
84
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$239K 0.09%
+3,000
New +$238K
QQQ icon
85
Invesco QQQ Trust
QQQ
$493B
$213K 0.08%
+2,700
New +$206K
PMCS
86
DELISTED
P M C SIERRA INC
PMCS
$132K 0.05%
20,000
– –
CORV
87
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$61K 0.02%
17,280
– –
BMY icon
88
Bristol-Myers Squibb
BMY
$137B
– –
-4,895
Closed -$219K
HUM icon
89
Humana
HUM
$47.1B
– –
-3,145
Closed -$265K
NEOG icon
90
Neogen
NEOG
$2.56B
– –
-77,240
Closed -$1.07M
PFE icon
91
Pfizer
PFE
$160B
– –
-7,800
Closed -$207K
SGMO
92
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-320,700
Closed -$2.5M
NUVA
93
DELISTED
NuVasive, Inc.
NUVA
– –
-20,974
Closed -$520K
UPI
94
DELISTED
UROPLASTY INC-NEW
UPI
– –
-132,211
Closed -$274K
LIFE
95
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
– –
-9,868
Closed -$730K
ONXX
96
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
– –
-8,965
Closed -$778K
WCRX
97
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
– –
-12,905
Closed -$257K
1 2 3
4

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Kopp Investment Advisors held 97 positions worth $272M, up 6.3% from $256M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Kopp Investment Advisors withdrew a net $33.7M in Q3 2013, closing 10 positions and reducing 69 holdings. Its most notable exit was SANGAMO THERAPEUTICS INC, an estimated $2.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Kopp Investment Advisors opened a new position in TELLABS INC worth $1.69M.

  • Kopp Investment Advisors's largest Q3 2013 buy was TELLABS INC: 742,690 shares worth $1.69M.
  • Kopp Investment Advisors added most to Oclaro Inc. in Q3 2013, an estimated $3.07M increase.
  • Kopp Investment Advisors's biggest Q3 2013 reduction was Akorn Inc, cutting an estimated $6.1M.
  • Kopp Investment Advisors fully exited SANGAMO THERAPEUTICS INC in Q3 2013, selling an estimated $2.5M.
  • Kopp Investment Advisors's ten largest holdings make up 50% of its $272M portfolio in Q3 2013.
  • Kopp Investment Advisors opened 4 new positions and closed 10 in Q3 2013.
  • Kopp Investment Advisors's portfolio value rose 6.3% quarter-over-quarter to $272M.

Based on Kopp Investment Advisors's 13F filing for Q3 2013, filed 1 Nov 2013.